{{Rsnum
|rsid=10868366
|Gene=GOLM1
|Chromosome=9
|position=86085145
|Orientation=plus
|GMAF=0.3205
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=GOLM1
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 85.8 | 13.3 | 0.9
| HCB | 21.9 | 53.3 | 24.8
| JPT | 19.5 | 49.6 | 31.0
| YRI | 10.2 | 44.9 | 44.9
| ASW | 35.1 | 49.1 | 15.8
| CHB | 21.9 | 53.3 | 24.8
| CHD | 27.4 | 43.4 | 29.2
| GIH | 55.4 | 36.6 | 7.9
| LWK | 22.9 | 49.5 | 27.6
| MEX | 77.2 | 21.1 | 1.8
| MKK | 38.5 | 42.9 | 18.6
| TSI | 79.4 | 19.6 | 1.0
| HapMapRevision=28
}}
[[rs10868366]], a SNP in the [[GOLM1]] gene, is associated with reduced risk for [[Alzheimer's disease]] in a study of ~1100 Canadian patients. The protective allele appears to be [[rs10868366(T)]], giving an odds ratio of 0.55 (CI: 0.40 - 0.75). {{PMID|17998437}} 

{{PMID Auto
|PMID=20570408
|Title=Genetic variation in GOLM1 and prefrontal cortical volume in Alzheimer's disease
}}

{{PMID|19749441}} GOLPH2 gene markers are not associated with Alzheimer's disease in a sample of the Spanish population.

{{PMID|20574532|OA=1
}} Intermediate phenotypes identify divergent pathways to Alzheimer's disease.

{{PMID|22167654}} Association studies of 19 candidate SNPs with sporadic Alzheimer's disease in the North Chinese Han population.

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}